Bioreactor Startup Comes Together Using Soviet Technology And U.S. Financing

In an unprecedented deal, RiboGene Inc. is putting a Soviet team's advanced research into production with American money MENLO PARK, Calif.A year and a half ago, venture capitalist Petri Vainio was considering buying into a proposal from protein chemist and would-be entrepreneur Kin-Ping Wong. So Vainio began an investigation commonly performed by patent attorneys to see whether any other inventor, anywhere in the world, had come up with a similar idea. Vainio discovered that a group of Sovie

Ta Heppenheimer

| 5 min read

Listen with Speechify

0:00

5:00

In an unprecedented deal, RiboGene Inc. is putting a Soviet team's advanced research into production with American money

MENLO PARK, Calif.A year and a half ago, venture capitalist Petri Vainio was considering buying into a proposal from protein chemist and would-be entrepreneur Kin-Ping Wong. So Vainio began an investigation commonly performed by patent attorneys to see whether any other inventor, anywhere in the world, had come up with a similar idea.

Vainio discovered that a group of Soviet scientists not only was working on the very same project, but also was way ahead of Wong. Rather than dump Wong's plan, deal-maker Vainio incorporated both their talents, and after a year of intercontinental negotiations, he and Wong announced a collaboration unprecedented in the annals of biotechnology startups: a company built upon money and management from the United States, but using Soviet technology. RiboGene Inc., incorporated in May, began with the idea ...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!

Join for free today

Already a member? Login Here